This growth is driven by years of focused efforts to develop innovative solutions that help researchers accelerate the discovery of better treatments and medications for patients with cardiometabolic diseases.

Mercodia’s commitment to delivering high-quality services and products has established it as a valued partner for organizations conducting research and clinical studies.

This move enables us to provide a more flexible, business-driven service with a local presence. It also positions us to better address the growing global demand for reliable solutions in the cardiometabolic field.

“We are incredibly proud of the growth we have achieved over the past few years and view our expansion into the U.S. as a natural step forward. This move enables us to provide a more flexible, business-driven service with a local presence. It also positions us to better address the growing global demand for reliable solutions in the cardiometabolic field. Our success reflects the expertise of our team, our strong customer focus, and our ability to deliver results,” comments Jörgen Dahlström, CEO, Mercodia.

A trusted partner for clinical research

With this new initiative in the U.S., Mercodia strengthens its ability to offer localized support and expertise to researchers working in the U.S. market. The company’s proven track record of successful collaborations and deep industry knowledge makes it a strong partner for clinical research.

Mercodia’s goal is to be more than just a supplier – the company aims to act as a strategic partner, contributing to the efficient, safe, and high-quality execution of clinical studies.

visit mercodia
This is Mercodia

Mercodia is a Swedish life science company and experienced bioanalytical CRO with over 30 years in the field, specializing in analytical solutions for large molecule therapeutics and biomarkers. We develop and manufacture high-quality immunoassays for research and clinical diagnostics, with a core focus on biomarkers for diabetes, obesity, and cardiometabolic diseases. From our GLP-compliant laboratories in Europe and the US, we provide cost-effective bioanalytical services spanning preclinical to clinical phases of drug development programs. 

We support pharmaceutical, biotech, and academic teams by ensuring regulatory compliance while optimizing cost and efficiency. Renowned for our reliability, scientific expertise, and commitment to quality, Mercodia is your trusted partner, helping scientists worldwide generate high-quality data for confident decision-making.

Contact

Jörgen Dahlström, CEO, Mercodia
jorgen.dahlstrom@mercodia.com